Glenmark Pharma Q3 FY11 Results : Net profit up 16.46%

by khalid on 02/02/2011 · 0 comments

Glenmark Pharmaceuticals Limited has posted a net profit for the period Q3 (ending Dec 10) of the current fiscal (FY10-11). During the said quarter, net profit rose 16.46% to Rs 109.55 crores in comparison to Rs 94.07 crores of Q3 (ending Dec 09) of previous year (FY09-10). Glenmark Pharmaceuticals Limited is an emerging, research-based global pharmaceutical company.

The company has informed the share market (BSE/NSE) that the total income has increased 20.84% to Rs 649.65 crore in Q3 (ending Dec 2010) of the current fiscal (FY10-11) when compared with the same quarter Q3 (ending Dec 2009) of previous year (FY09-10). Total income was Rs 785.06 crores in last year’s quarter Q3.

Share’s Data :-
BSE Code : 532296
Mkt. Cap : Rs 8,152.33 Crores
Glenmark Pharmaceuticals Ltd. share’s CMP is Rs 302.05 on 1st Feb 2011.

Stay tuned to BelltheBull Blog for more news on Glenmark Pharmaceuticals Limited !

Related Posts Plugin for WordPress, Blogger...

Leave a Comment

Previous post:

Next post: